Vaxart Inc (NASDAQ: VXRT) Stock’s Performance and Current Analyst Sentiments

In the latest trading session, 0.67 million Vaxart Inc (NASDAQ:VXRT) shares changed hands as the company’s beta touched 0.80. With the company’s most recent per share price at $0.74 changed hands at -$0.05 or -6.93% at last look, the market valuation stands at $167.22M. VXRT’s current price is a discount, trading about -108.11% off its 52-week high of $1.54. The share price had its 52-week low at $0.52, which suggests the last value was 29.73% up since then. When we look at Vaxart Inc’s average trading volume, we note the 10-day average is 3.68 million shares, with the 3-month average coming to 1.74 million.

Analysts gave the Vaxart Inc (VXRT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended VXRT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Vaxart Inc’s EPS for the current quarter is expected to be -0.11.

Vaxart Inc (NASDAQ:VXRT) trade information

Instantly VXRT was in red as seen in intraday trades today. With action -12.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 11.03%, with the 5-day performance at -12.22% in the red. However, in the 30-day time frame, Vaxart Inc (NASDAQ:VXRT) is 17.56% up. Looking at the short shares, we see there were 11.27 million shares sold at short interest cover period of 11.71 days.

The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 63.0% from its recent market value. According to analyst projections, VXRT’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -170.27% plunge from its current level, while the stock would need to soar -170.27% for it to hit the projected low.

Vaxart Inc (VXRT) estimates and forecasts

Data shows that the Vaxart Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 9.67% over the past 6 months, a 31.58% in annual growth rate that is considerably higher than the industry average of 16.20%. Year-over-year growth is forecast to reach 364.62% up from the last financial year.

Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 15.68M. 3 analysts are of the opinion that Vaxart Inc’s revenue for the current quarter will be 8.32M. The company’s revenue for the corresponding quarters a year ago was 3.25M and 2.18M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 383.34%. The estimates for the next quarter sales put growth at 281.71%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 27.81%. The 2025 estimates are for Vaxart Inc earnings to increase by 32.16%.

VXRT Dividends

Vaxart Inc is expected to release its next quarterly earnings report in February.

Vaxart Inc (NASDAQ:VXRT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.87% of Vaxart Inc shares while 17.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 17.96%. There are 17.80% institutions holding the Vaxart Inc stock share, with HERITAGE WEALTH ADVISORS the top institutional holder. As of 2024-06-30, the company held 9.5756% of the shares, roughly 21780.0 VXRT shares worth $14534.0.

SIO CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 8.7465% or 14.76 million shares worth $9.85 million as of 2024-06-30.

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 7.16 shares estimated at $5.17 million under it, the former controlled 3.15% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.11% of the shares, roughly 2.52 shares worth around $1.82 million.